186 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
With A Rebrand And A New App, Will WW International Rebound In 2020? https://www.fool.com/investing/2019/11/21/with-a-rebrand-and-a-new-app-will-ww-international.aspx?source=iedfolrf0000001 Nov 21, 2019 - Last week, Weight Watchers International rolled out myWW, offering members a customized approach to weight management. But will its new program and its rebranding effort help it recover from slimmer third-quarter revenue results?
NVO: Barclays ups to Overweight https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191118091502 Nov 18, 2019 - Barclays issues rating change for NVO
Here's Why AstraZeneca's (AZN) Shares Are Up Year to Date http://www.zacks.com/stock/news/625339/heres-why-astrazenecas-azn-shares-are-up-year-to-date?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-625339 Nov 18, 2019 - AstraZeneca's (AZN) stock is on an upward trajectory this year. Let us take a look at the reasons for the same.
4 Big Drugmakers to Bet on After a Great Earnings Season http://www.zacks.com/stock/news/621080/4-big-drugmakers-to-bet-on-after-a-great-earnings-season?cid=CS-ZC-FT-analyst_blog|investment_ideas-621080 Nov 15, 2019 - Big drugmakers post better-than-expected Q3 results, leading to rise in share price of most of the companies in the industry.
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes http://www.zacks.com/stock/news/619673/fda-panel-votes-against-lillys-jardiance-for-type-i-diabetes?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-619673 Nov 14, 2019 - Eli Lilly (LLY) gets an unfavorable FDA panel vote to expand the label of its type II diabetes medicine Jardiance (2.5 mg) for type I diabetes.
Top Analyst Reports for Microsoft, Novartis & Novo Nordisk http://www.zacks.com/research-daily/617786/top-analyst-reports-for-microsoft-novartis-novo-nordisk?cid=CS-ZC-FT-research_daily-617786 Nov 13, 2019 - Top Analyst Reports for Microsoft, Novartis & Novo Nordisk
Pharma Stock Roundup: AGN, NVO Q3 Earnings, FDA Nod to SNY & NVS' Products http://www.zacks.com/stock/news/610160/pharma-stock-roundup-agn-nvo-q3-earnings-fda-nod-to-sny-nvs-products?cid=CS-ZC-FT-analyst_blog|stock_roundup-610160 Nov 08, 2019 - Novo Nordisk (NVO) and Allergan (AGN) release Q3 results. FDA approves Sanofi's quadrivalent flu vaccine for older adults and Novartis' long-acting biosimilar version of Amgen's Neulasta.
Novo Nordisk (NVO) Q3 Earnings Beat Estimates, Revenues Miss http://www.zacks.com/stock/news/602358/novo-nordisk-nvo-q3-earnings-beat-estimates-revenues-miss?cid=CS-ZC-FT-analyst_blog|earnings_article-602358 Nov 04, 2019 - Novo Nordisk (NVO) beats earnings estimates but misses sales estimates in the third quarter of 2019.
Novo Nordisk A/S (NVO) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/11/01/novo-nordisk-as-nvo-q3-2019-earnings-call-transcri.aspx?source=iedfolrf0000001 Nov 01, 2019 - NVO earnings call for the period ending September 30, 2019.
Novo Nordisk A/S (NVO) CEO Lars Jørgensen on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4301542-novo-nordisk-s-nvo-ceo-lars-jorgensen-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Nov 01, 2019 - Novo Nordisk A/S (NYSE:NVO) Q3 2019 Earnings Conference Call November 01, 2019, 08:00 ET Company Participants Lars Jørgensen - President & CEO Mads Thomsen - EVP & Chief Science Officer Karste

Pages: 123456...19

Page 1>